Author/Authors :
Wang، نويسنده , , Yin and Liu، نويسنده , , Yan and Wu، نويسنده , , Cindy and Zhang، نويسنده , , Huiming and Zheng، نويسنده , , Xincheng and Zheng، نويسنده , , Zhi and Geiger، نويسنده , , Terrence L. and Nuovo، نويسنده , , Gerard J. and Liu، نويسنده , , Yang and Zheng، نويسنده , , Pan، نويسنده ,
Abstract :
Summary
netic mechanisms responsible for increased incidence of lymphoma in immunocompromised individuals have not been fully elucidated. We show that, in a line of TCR transgenic TG-B mice, an insertional mutation in one allele of the Epm2a locus and epigenetic silencing of another led to a high rate of lymphoma with early onset. Overexpressing Epm2a suppressed the growth of established tumor cells and the development of lymphoma in the TG-B mice, while specific silencing of the locus increased tumorigenesis in the immune-deficient host. Downregulation of Epm2a expression is widespread among mouse and human lymphoma cell lines. Epm2a-encoded laforin is a phosphatase for GSK-3β and an important repressor in the Wnt signaling pathway. Inactivation of Epm2a resulted in increased Wnt signaling and tumorigenesis.